Post #4811

🇩🇪🇺🇸Western mRNA Vaccine Trial Yields Breakthrough Cancer Results A groundbreaking trial for a personalized mRNA cancer vaccine, developed by BioNTech, is showing remarkable potential against pancreatic cancer. The innovative therapy trains a patient's immune system to target their specific tumor mutations post-surgery. In a small-scale study, half of the 16 participants mounted a strong immune response. Critically, nearly all of these responders remained alive up to six years later, a significant outcome for one of the deadliest cancers. Minas Tirith | 24/7 News channel